NSGC 2026 has ended. This guide stays up as the record of who was there. Next: NSGC 2027, Nov 7–11, 2027 in Tampa

Acadia Pharmaceuticals at NSGC 2026

Nov 10–14, 2026 Baltimore, MD ~2.5k attendees Website

Acadia Pharmaceuticals takes part in 1 session at NSGC 2026 in Baltimore, and exhibits at Booth 963. Its breakfast symposium covers managing Rett syndrome with DAYBUE and DAYBUE STIX, the two forms of the company's FDA-approved treatment for the condition. Acadia Pharmaceuticals also has an approved medicine for Parkinson's disease psychosis and is developing more for neurological and rare conditions.

OrganizationNSGC 2026 Attendance
Pharma and biotech companies
Biopharmaceutical company with approved treatments for Rett syndrome and Parkinson's disease psychosis, developing further medicines for neurological and rare conditions.
Booth
Exhibiting at Booth 963
Wed, Nov 1110am–12:15pm · 3–6:30pmThu, Nov 1210:15am–12:15pm · 3–5:30pmFri, Nov 1310:15am–12:15pm
Symposium
Fri Nov 13
7:45–8:30am
Rett Syndrome Management Your Way: Two Formulations of the First and Only FDA-Approved Treatment
Covers Rett syndrome care with both forms of Acadia's FDA-approved Rett treatment, DAYBUE and DAYBUE STIX.
Neurology · Rare disease

Explore the full NSGC 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Baltimore. Leave your work email and we’ll be in touch.

Privacy

Download the full NSGC 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Acadia Pharmaceuticals

Tell us what you sell and we’ll find the people at Acadia Pharmaceuticals most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the National Society of Genetic Counselors (NSGC). Organization details are derived from NSGC’s published exhibitor list and program, and each organization’s own website. Submit a correction